Amine Belaïd

9.5k total citations
22 papers, 821 citations indexed

About

Amine Belaïd is a scholar working on Molecular Biology, Epidemiology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Amine Belaïd has authored 22 papers receiving a total of 821 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 10 papers in Epidemiology and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Amine Belaïd's work include Autophagy in Disease and Therapy (10 papers), Tuberous Sclerosis Complex Research (4 papers) and Renal cell carcinoma treatment (3 papers). Amine Belaïd is often cited by papers focused on Autophagy in Disease and Therapy (10 papers), Tuberous Sclerosis Complex Research (4 papers) and Renal cell carcinoma treatment (3 papers). Amine Belaïd collaborates with scholars based in France, United States and Germany. Amine Belaïd's co-authors include Paul Hofman, Baharia Mograbi, Patrick Brest, Marius Ilié, Charles‐Hugo Marquette, Daniel J. Klionsky, Michel Tauc, Jérôme Mouroux, Fabrice Barlési and C. Sanfiorenzo and has published in prestigious journals such as PLoS ONE, Cancer Cell and Cancer Research.

In The Last Decade

Amine Belaïd

22 papers receiving 815 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amine Belaïd France 13 510 295 243 91 74 22 821
Yue Zong China 7 506 1.0× 196 0.7× 179 0.7× 42 0.5× 33 0.4× 9 777
Siyuan Yan China 15 366 0.7× 135 0.5× 184 0.8× 63 0.7× 10 0.1× 33 606
Ken‐ichi Aisaki Japan 14 452 0.9× 101 0.3× 108 0.4× 77 0.8× 65 0.9× 27 879
Manabu Iwadate Japan 11 530 1.0× 332 1.1× 118 0.5× 59 0.6× 9 0.1× 32 966
Oh Kwang Kwon South Korea 15 310 0.6× 83 0.3× 71 0.3× 60 0.7× 23 0.3× 30 533
Christelle Pigeon France 11 283 0.6× 81 0.3× 123 0.5× 55 0.6× 45 0.6× 12 2.0k
Walid Mahfouf France 14 452 0.9× 178 0.6× 137 0.6× 31 0.3× 8 0.1× 20 675

Countries citing papers authored by Amine Belaïd

Since Specialization
Citations

This map shows the geographic impact of Amine Belaïd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amine Belaïd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amine Belaïd more than expected).

Fields of papers citing papers by Amine Belaïd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amine Belaïd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amine Belaïd. The network helps show where Amine Belaïd may publish in the future.

Co-authorship network of co-authors of Amine Belaïd

This figure shows the co-authorship network connecting the top 25 collaborators of Amine Belaïd. A scholar is included among the top collaborators of Amine Belaïd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amine Belaïd. Amine Belaïd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Belaïd, Amine, Jonathan Benzaquen, Valérie Vouret‐Craviari, et al.. (2024). Impact of the Lung Microbiota on Development and Progression of Lung Cancer. Cancers. 16(19). 3342–3342. 4 indexed citations
2.
Belaïd, Amine, et al.. (2024). Targeting cancer and immune cell metabolism with the complex I inhibitors metformin and IACS‐010759. Molecular Oncology. 18(7). 1719–1738. 23 indexed citations
3.
Grosjean, Iris, Amine Belaïd, Romain K. Gherardi, et al.. (2022). Autophagopathies: from autophagy gene polymorphisms to precision medicine for human diseases. Autophagy. 18(11). 2519–2536. 25 indexed citations
4.
Grosjean, Iris, Amine Belaïd, Éric Gilson, et al.. (2022). Abstract 1284: The tumor scaffold protein SQSTM1 at the crossroads of DNA damage and immunotherapy responses in solid tumors. Cancer Research. 82(12_Supplement). 1284–1284. 1 indexed citations
5.
Belaïd, Amine & Harilaos Filippakis. (2021). Quantitative Assessment of Macropinocytosis in mTORC1-Hyperactive Cells using Flow Cytometry. Journal of Visualized Experiments. 1 indexed citations
6.
Chargui, Abderrahman, Amine Belaïd, Papa Diogop Ndiaye, et al.. (2021). The Carcinogen Cadmium Activates Lysine 63 (K63)-Linked Ubiquitin-Dependent Signaling and Inhibits Selective Autophagy. Cancers. 13(10). 2490–2490. 9 indexed citations
7.
Filippakis, Harilaos, Amine Belaïd, Brian J. Siroky, et al.. (2018). Vps34-mediated macropinocytosis in Tuberous Sclerosis Complex 2-deficient cells supports tumorigenesis. Scientific Reports. 8(1). 14161–14161. 12 indexed citations
8.
Valvezan, Alexander J., Marc Turner, Amine Belaïd, et al.. (2017). mTORC1 Couples Nucleotide Synthesis to Nucleotide Demand Resulting in a Targetable Metabolic Vulnerability. Cancer Cell. 32(5). 624–638.e5. 110 indexed citations
9.
Belaïd, Amine, Harilaos Filippakis, Hilaire C. Lam, et al.. (2017). Abstract A09: Therapeutic targeting of TSC2-deficient cells with Methotrexate: Results of a drug repurposing screen. Clinical Cancer Research. 23(1_Supplement). A09–A09. 1 indexed citations
10.
Giuliano, Sandy, Yann Cormerais, Maeva Dufies, et al.. (2016). Resistance to sunitinib in clear cell renal cell carcinoma results from drug sequestration in lysosomes and inhibition of autophagic flux. European Journal of Cancer. 61. S138–S138. 1 indexed citations
11.
Mélis, Nicolas, Isabelle Rubera, Marc Cougnon, et al.. (2016). Targeting eIF5A Hypusination Prevents Anoxic Cell Death through Mitochondrial Silencing and Improves Kidney Transplant Outcome. Journal of the American Society of Nephrology. 28(3). 811–822. 52 indexed citations
12.
Belaïd, Amine, Papa Ibnou Ndiaye, Harilaos Filippakis, et al.. (2015). Autophagy : Moving Benchside Promises to Patient Bedsides. Current Cancer Drug Targets. 15(8). 684–702. 13 indexed citations
13.
Giuliano, Sandy, Yann Cormerais, Maeva Dufies, et al.. (2015). Resistance to sunitinib in renal clear cell carcinoma results from sequestration in lysosomes and inhibition of the autophagic flux. Autophagy. 11(10). 1891–1904. 98 indexed citations
14.
Belaïd, Amine, Michaël Cerezo, Abderrahman Chargui, et al.. (2013). Autophagy Plays a Critical Role in the Degradation of Active RHOA, the Control of Cell Cytokinesis, and Genomic Stability. Cancer Research. 73(14). 4311–4322. 78 indexed citations
15.
Sanfiorenzo, C., Marius Ilié, Amine Belaïd, et al.. (2013). Two Panels of Plasma MicroRNAs as Non-Invasive Biomarkers for Prediction of Recurrence in Resectable NSCLC. PLoS ONE. 8(1). e54596–e54596. 141 indexed citations
16.
Belaïd, Amine, Papa Diogop Ndiaye, Daniel J. Klionsky, Paul Hofman, & Baharia Mograbi. (2013). Signalphagy. Autophagy. 9(10). 1629–1630. 16 indexed citations
17.
Chargui, Abderrahman, et al.. (2013). Autophagy: A Major Target of Cadmium Nephrotoxicity. Current Chemical Biology. 7(2). 177–187. 1 indexed citations
18.
Belaïd, Amine, Papa Diogop Ndiaye, Michaël Cerezo, et al.. (2013). Autophagy and SQSTM1 on the RHOA(d) again. Autophagy. 10(2). 201–208. 30 indexed citations
19.
Chargui, Abderrahman, S. Zekri, Grégory Jacquillet, et al.. (2011). Cadmium-Induced Autophagy in Rat Kidney: An Early Biomarker of Subtoxic Exposure. Toxicological Sciences. 121(1). 31–42. 122 indexed citations
20.
Brest, Patrick, Elisabeth Corcelle–Termeau, Annabelle Césaro, et al.. (2010). Autophagy and Crohns Disease: At the Crossroads of Infection, Inflammation, Immunity, and Cancer. Current Molecular Medicine. 10(5). 486–502. 64 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026